Literature DB >> 18382194

Pathophysiology of septic acute kidney injury: what do we really know?

Li Wan1, Sean M Bagshaw, Christoph Langenberg, Takao Saotome, Clive May, Rinaldo Bellomo.   

Abstract

Septic acute kidney injury accounts for close to 50% of all cases of acute kidney injury in the intensive care unit and, in its various forms, affects between 15% and 20% of intensive care unit patients. However, there is little we really know about its pathophysiology. Although hemodynamic factors might play a role in the loss of glomerular filtration rate, they may not act through the induction of renal ischemia. Septic acute renal failure may, at least in patients with a hyperdynamic circulation, represent a unique form of acute renal failure: hyperemic acute renal failure. Measurements of renal blood flow in septic humans are now needed to resolve this pivotal pathophysiological question. Whatever may happen to renal blood flow during septic acute kidney injury in humans, the evidence available suggests that urinalysis fails to provide useful diagnostic or prognostic information in this setting. In addition, nonhemodynamic mechanisms of cell injury are likely to be at work. These mechanisms are likely due to a combination of immunologic, toxic, and inflammatory factors that may affect the microvasculature and the tubular cells. Among these mechanisms, apoptosis may turn out to be important. It is possible that, as evidence accumulates, the paradigms currently used to explain acute renal failure in sepsis will shift from ischemia and vasoconstriction to hyperemia and vasodilation and from acute tubular necrosis to acute tubular apoptosis or simply tubular cell dysfunction or exfoliation. If this were to happen, our therapeutic approaches would also be profoundly altered.

Entities:  

Mesh:

Year:  2008        PMID: 18382194     DOI: 10.1097/CCM.0b013e318168ccd5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  110 in total

1.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

2.  Sepsis and AKI: more complex than just a simple question of chicken and egg.

Authors:  P M Honoré; R Jacobs; W Boer; O Joannes-Boyau
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  CIDEC Is Involved in LPS-Induced Inflammation and Apoptosis in Renal Tubular Epithelial Cells.

Authors:  Jin He; Bin Zhang; Hua Gan
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

5.  The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis.

Authors:  Nermin A H Sadik; Waleed A Mohamed; Mohamed I Ahmed
Journal:  Mol Cell Biochem       Date:  2011-08-03       Impact factor: 3.396

6.  Evaluation and management of acute kidney injury in the intensive care unit.

Authors:  Timothy M Saettele; Jason Mohr; Gary A Salzman
Journal:  Mo Med       Date:  2012 Sep-Oct

7.  Juvenile OLFM4-null mice are protected from sepsis.

Authors:  Julie E Stark; Amy M Opoka; Jaya Mallela; Prasad Devarajan; Qing Ma; Nick C Levinsky; Keith F Stringer; Hector R Wong; Matthew N Alder
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

8.  Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department.

Authors:  Rossella Marino; Joachim Struck; Oliver Hartmann; Alan S Maisel; Miriam Rehfeldt; Laura Magrini; Olle Melander; Andreas Bergmann; Salvatore Di Somma
Journal:  J Nephrol       Date:  2014-12-09       Impact factor: 3.902

9.  Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.

Authors:  Sean M Bagshaw; Michael Bennett; Michael Haase; Anja Haase-Fielitz; Moritoki Egi; Hiroshi Morimatsu; Giuseppe D'amico; Donna Goldsmith; Prasad Devarajan; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

10.  Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages.

Authors:  Liang Chen; Sixing Yang; Elizabeth E Zumbrun; Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2015-03-18       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.